Fidelity Advisor Biotechnology Fund Accounts Payable

Fidelity Advisor Biotechnology Fund (FBTTX) currently reports a accounts payable of $16M as of February 2024. That compares with $10M in the prior-year period — up 57.2% year over year. Use the charts on this page to explore Fidelity Advisor Biotechnology Fund's accounts payable history and peer comparisons.

Fidelity Advisor Biotechnology Fund's accounts payable increased from $10M to $16M — a 57.2% year-over-year increase (period ending February 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fidelity Advisor Biotechnology Fund reported $16M in accounts payable as of February 2024. That compares with $10M in the prior-year period — up 57.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fidelity Advisor Biotechnology Fund, and consider following FBTTX for alerts when major investors trade the stock.